Sirolimus in Treating Patients With Angiomyolipoma of the Kidney - Related Studies

Sirolimus in Treating Patients With Angiomyolipoma of the Kidney

This study is ongoing, but not recruiting participants.

Study NCT00126672. Last updated on October 8, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Precancerous/Nonmalignant Condition

2	Additional conditions recognized in this trial
		Angiomyolipoma
		Precancerous Conditions

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Adipose Tissue
		Neoplasms, Connective and Soft Tissue

4	Interventions listed in this trial
		sirolimus

5	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		Dana-Farber Cancer Institute
		National Cancer Institute (NCI)